According to the neurotrophic hypothesis of depression, stress can lead to brain atrophy by modifying brain-derived neurotrophic factor (BDNF) levels. Given that BDNF secretion is affected by a common polymorphism (rs6265, Val66Met), which also is associated with depression, we investigated whether this polymorphism modifies the effect of childhood adversity (CA) on local gray matter (GM) volume in depression-relevant brain regions, using data from two large cohorts of healthy subjects. We included 568 healthy volunteers (aged 18-50 years, 63% female) in our study, for whom complete data were available, with magnetic resonance imaging data at 1.5 Tesla (N = 275) or 3 Tesla (N = 293). We used a whole brain optimized voxel-based morphometry (VBM) approach assessing genotype-dependent GM differences, with focus on the amygdala, hippocampus and medial prefrontal cortex (PFC; including anterior cingulate cortex (ACC) and orbitomedial PFC). CA was assessed using a validated questionnaire. In both cohorts, we found that BDNF methionine (Met)-allele carriers with a history of CA had significantly less GM in subgenual ACC (P < 0.05) compared with Metallele carriers without CA and Val/Val homozygotes with CA. No differences were found in hippocampus, amygdala and orbitomedial PFC. On the basis of our findings, we conclude that BDNF Met-allele carriers are particularly sensitive to CA. Given the key role of the subgenual ACC in emotion regulation, this finding provides an important mechanistic link between stress and BDNF on one hand and mood impairments on the other hand.
Introduction
The experience of childhood adversity (CA) constitutes a major risk factor for psychiatric disorders. 1 Early life stress has also frequently been associated with structural brain alterations, particularly in those brain areas that mature late, such as the hippocampus and prefrontal cortex (PFC). [2] [3] [4] Such structural brain alterations may be caused by a lack of neurotrophic factors, whose synthesis is reduced in the aftermath of stress. 5 For instance, it has been shown in rodents that stress reduces brain-derived neurotrophic factor (BDNF) levels in the hippocampus and PFC. 6 Also in humans, hippocampal and prefrontal BDNF levels are lower in depressed persons having committed suicide, compared with control subjects. 7, 8 There is, however, a large inter-individual variability in stress susceptibility. The leading explanation for this variability proposes that genetic variance modulates the effect of stress on the brain. 9, 10 Indeed, numerous studies have shown that persons with a specific genetic make-up are more prone to develop stress-related mental disorders after experiencing major life events like CA. [11] [12] [13] Moreover, recent studies suggest that gene by stress interactions may be involved in inter-individual differences in local brain volume 14 and may also have a role in the onset of several psychiatric disorders, like bipolar disorder, schizophrenia, attention deficit hyperactivity disorder and depression (for review see 15 ). In case of depression, it has been suggested that gene by stress interactions may explain up to 60-70% of the variance in disease susceptibility. 16 A common functional polymorphism in the BDNF gene (rs6265, Val66Met) seems to be a relevant candidate for such an effect. 17 This polymorphism leads to an amino acid substitution (valine to methionine) at codon 66 in the prodomain of the protein, which impairs intracellular trafficking and activity-dependent secretion of BDNF 18 and has been implicated in the etiology of depression. 19 Previously, Joffe et al. 20 were the first to show an interaction between the BDNF polymorphism and stress in healthy subjects; they found a significant relation between stress susceptibility and decreased hippocampal volume in methionine (Met)-allele carriers, but no effect in subjects with the ValVal genotype. Additionally, in another study by Gatt et al., 17 who studied the interaction between BDNF Val66met and CA on local brain volume, differences in amygdala and hippocampal volume were found. These authors showed that, compared with Val/Val homozygotes, a high number of childhood events was associated with a moderate volume reduction of hippocampus and amygdala in persons carrying the Met-allele of the BDNF polymorphism, but found no main effects of either BDNF or CA. However, these findings were obtained using volumetry of pre-specified regions and thus, it is unclear whether other brain areas are also affected by an interaction between BDNF and CA.
Therefore, we sought to investigate to which extent BDNF genotype can modify the effect of CA on local gray matter (GM) changes, using a whole-brain optimized voxel-based morphometry (VBM) approach. By doing so, we could localize any effects. We used data from two large cohorts of healthy subjects. This way, we were able to replicate our findings, reducing the risk of type II errors. We also avoided possible confounding effects of disease, comorbidity and treatment by investigating healthy subjects.
Methods

Subjects
This study was part of the Brain Imaging Genetics study at the Donders Institute for Brain, Cognition and Behavior of the Radboud University Nijmegen (Medical Centre). 21 All participants were of Caucasian descent and were screened before study participation, using a self-report questionnaire for the following exclusion criteria: a history of somatic disease potentially affecting the brain, current or past psychiatric or neurological disorder, medication (except hormonal contraceptives) or illicit drug use during the past 6 months, history of substance abuse, current or past alcohol dependence, pregnancy, lactation, menopause and magnetic resonance imaging contraindications.
The sample was made up of two independent cohorts based on the scanner used. These were analyzed separately, to provide an independent replication of the results.
Tesla cohort.
A total of 275 healthy subjects were scanned using a 1.5 Tesla magnetic resonance imaging scanner. The participants were aged 18-50 years, with a mean age of 23.7 years (s.d. = 6.0). The majority was female (63%) and had a university or equivalent degree (61%).
3 Tesla cohort. A total of 293 healthy subjects were scanned using a 3 Tesla magnetic resonance imaging scanner. Participants were 18-50 years old, with a mean age of 23.1 years (s.d. = 4.7). The majority was female (64%) and had a university or equivalent degree (73%).
Assessment of CA CA was assessed using an adapted version of the List of Threatening Life Events developed by Brugha et al., 22 with the aim of assessing the stress of life events. This inventory encompasses life events, which are likely to occur relatively frequently and score relatively high on long-term threat. Participants were asked whether they had experienced a list of predefined events before the age of 16. This list comprised events like death of a parent, severe illness of self or spouse, moving house and sexual or physical abuse. Presence of CA was defined as having experienced at least one CA before the age of 16 years. Additionally, we also conducted analyses with CA dichotomized into presence of two or more CA versus no or one CA, as in an earlier study, which showed that only in persons with a history of two or more CA, differences in brain volumes were found. 17 
Genotyping
Genetic analyses were carried out at the Department of Human Genetics of the Radboud University Nijmegen Medical Centre, in a laboratory, which has a quality certification according to CCKL criteria. High molecular weight DNA was isolated from saliva using Oragene containers (DNA Genotek, Ottawa, Ontario, Canada), according to the protocol supplied by the manufacturer. The BDNF 198-G > A (rs6265) polymorphism (Val66Met) was genotyped using Taqman analysis (assay ID: C_11592758_10; Applied Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). Genotyping was carried out in a volume of 10 ml containing 10 ng of genomic DNA, 5 ml of Taqman Mastermix (2 Â ; Applied Biosytems), 0.375 ml of the Taqman assay and 3.625 ml of H 2 O. Genotyping was performed on a 7500 Fast Real-Time PCR System and genotypes were scored using the algorithm and software supplied by the manufacturer (Applied Biosystems). The genotyping assay had been validated before use and 5% duplicates and blanks were taken along as quality controls during genotyping. Testing for Hardy-Weinberg equilibrium did not show deviations from the expected genotype distribution (P > 0.05). Subjects homozygous and heterozygous for the Met-allele were merged into a group of Met-carriers and compared with homozygous Val-allele carriers.
Mood state
To avoid confounding by current mood state, we adjusted the analyses for the negative affect scale of the Positive Affect and Negative Affect Schedule (PANAS). 23 Magnetic resonance image acquisition All scans covered the entire brain and had a voxel size of 1 Â 1 Â 1 mm 3 .
1.5 Tesla cohort. All images were acquired at 1.5T Siemens Sonata or Avanto scanners (Siemens, Erlangen, Germany), using small variations to a standard T1-weighted 3D MPRAGE sequence (TR 2300 ms, TI 1100 ms, TE Magnetic resonance image conversion Raw DICOM magnetic resonance imaging data were converted to NIFTI format using the conversion as implemented in SPM5 (http://www.fil.ion.ucl.ac.uk/ spm/software/spm5/).
Brain volume
Normalizing, bias-correcting and segmenting into GM, white matter and cerebrospinal fluid was performed using the VBM5.1 Toolbox version 1.19 (http:// dbm.neuro.uni-jena.de/vbm/) in SPM, using earlier default settings. This method uses an optimized VBM protocol, 24 as well as a model based on Hidden Markov Random Fields, developed to increase signal-to-noise ratio. 25 Total volume of GM, white matter and cerebrospinal fluid was calculated by adding the resulting tissue probabilities. Total brain volume was defined as the sum of white matter and GM volume.
Voxel-based morphometry (VBM) Diffeomorphic Anatomical Registration using Exponentiated Lie algebra (DARTEL) registration toolbox in SPM 26 was applied. First, all images were realigned to templates created from 556 in-house datasets. Second, Jacobian-scaled ('modulated') images were calculated and subsequently transformed to Montréal Neurological Institute space, using affine transformation. Finally, all data were smoothed with an 8 mm FWHM Gaussian smoothing kernel. Analysis was performed in SPM using the GM images. After grouping all datasets according to genotype, images with poor quality or artifacts were identified using the outlier analysis routine implemented in the VBM toolbox. Images that showed a deviation of more than 1.5 times the interquartile range from the median were discarded from further analysis.
A full-factorial analysis of covariance was applied on the GM images using genotype and CA as factors and age, gender, total brain volume, scan protocol and PANAS negative scale as covariates. All statistical tests were family-wise error rate (FWE) corrected for multiple comparisons across the entire brain (P FWE < 0.05) or across all voxels in a region of interest using a small volume correction (SVC; P SVC < 0.05). Regions of interest (ROIs) for the amygdala, hippocampus and medial PFC were based on a standardized neuroanatomical atlas. 27, 28 Here, we defined the medial PFC as encompassing the anterior cingulate cortex (ACC) (y > 10; 29 ) and the medial part of the inferior, middle and superior frontal gyri, sometimes referred to as 'medial frontal gyrus', that is to say Brodmann areas 24, 25 and 32, as well as the medial part of Brodmann areas 9 and 10. 30 For visualization purposes, significant clusters were extracted using the toolbox MarsBar, version 0.42. 31 First, the main effects of CA and BDNF genotype on local GM volume were evaluated. Second, the interaction between CA and BDNF genotype on GM was tested by adding an interaction term to the statistical models. In all analyses, age, sex, total brain volume, PANAS negative scale and dummy regressors for the scan protocols were included as covariates. In case of a significant interaction, t-contrasts were created in SPM for post-hoc testing using P SVC < 0.05 for corresponding region of interest.
Results
There were no significant differences between the two cohorts on any of the sample characteristics (Table 1) . Total brain volume measured at 3T appeared significantly smaller than that measured at 1.5T. 32 No significant main effect of BDNF genotype on GM volume was found in either cohort, neither within the whole brain analysis (P FWE > 0.05), nor within the regional specific ROI analysis (all P SVC > 0.05). Within the 1.5T cohort, we found that a history of CA was related to less GM in the ACC (BA24) (P SVC = 0.02) and the medial orbitofrontal cortex (BA9) (P SVC = 0.05). However, these findings could not be replicated at 3T.
The interaction between BDNF genotype and CA did not lead to significant effects observable in the whole brain analysis (P FWE > 0.05). In the ROI analysis, however, we found an interaction effect in the subgenual ACC volume in both cohorts (BA 25, on 1.5 T P SVC = 0.006; on 3T P SVC = 0.019; see Figure 1 ). Additionally, the interaction affected the volume of the medial orbitofrontal cortex (BA10) (on 1.5 T P SVC = 0.02), but this effect could not be replicated in the 3T cohort (on 3T P SVC = 0.22). No interaction effects were found in amygdala or hippocampus. For more detailed description of results see Table 2 .
Using simple t-tests with contrasts for each comparison, Met-carriers were found to be more vulnerable to the effect of CA than homozygous Val-carriers (Figure 2) . Within the 1.5T cohort, Met-carriers with a history of CA had less GM in the subgenual ACC than Val-homozygotes with a history of CA (T = 3.33; P SVC = 0.007) and Met-carriers without a history of CA (T = 4.70; P SVC < 0.001). Similarly, within the 3T cohort, the comparison of Met-carriers and Val-homozygotes with a history of CA showed significantly less GM in the former (T = 3.30; P SVC = 0.002). The difference between Met-carriers with and without CA did not reach significance within the 3T cohort, though (T = 3.46; P SVC = 0.12).
In an attempt to replicate findings of a previous study, 17 we re-analyzed our data using two CA as the threshold for the presence of CA; however, these analyses did not change the associations found in our previous analyses.
Discussion
Within two independent cohorts of healthy subjects, we found that carriers of at least one Met-allele of the Val66Met polymorphism in BDNF who had a history of CA had decreased GM volume in the subgenual ACC, compared with Val-homozygotes and Metcarriers without a history of CA.
Amygdala, hippocampus and medial PFC have a vital role in normal emotional processing and the maturation of these areas continues into adolescence. 33 Consequently, we hypothesized that these brain areas might be most vulnerable to environmental adversities during childhood and adolescence. The medial PFC is the last part of the brain to mature 34 and therefore might have been the most sensitive to CA as measured in our study. Within the 1.5T cohort, we indeed found that persons with a history of CA showed a reduction of GM in the orbital PFC as compared with persons without CA. This finding could, however, not be replicated within the 3T cohort and it remains, therefore, unclear whether this was a false positive finding or whether this nonreplication was caused by higher levels of image distortion and signal dropout at 3T, which particularly affect the orbitofrontal and anterior temporal areas. Consequently, these areas are measured with greater reliability at 1.5T than at 3T. 32, 35 The subgenual ACC is also part of the medial PFC and has a role in emotion regulation 36 and negative memory bias, 37, 38 as shown by functional neuroimaging studies. Reduced GM volume in the subgenual ACC has previously been found in persons with a history of CA 39 as well, and volume reduction in this area is a consistent finding in mood disorders (for review see 40 ). Furthermore, the subgenual ACC has been shown to have a key role in the autonomic and neuroendocrine stress response and arousal associated with emotional states and behavior. 41, 42 Taken together, these results suggest that the subgenual ACC is implicated in the pathophysiology of mood and anxiety disorders and that decreased GM volume, as detected in our study, could be an indicator of increased emotional sensitivity as a result of genetic susceptibility interacting with CA.
Contrary to preceding studies among healthy subjects, [43] [44] [45] [46] we did not find a main effect of the BDNF Val66Met polymorphism on regional brain volume. We had expected to find reduced GM volume in Met-allele carriers, irrespective of CA. However, null findings have also been reported before. 20, 47, 48 It thus seems that the effect of the Val66Met polymorphism on regional brain volume is dependent on additional factors that have not been properly controlled for so far. For instance, Szeszko et al. 49 concluded that the effect of the Val66Met polymorphism on regional brain volume is pronounced in patients with schizophrenia. Our findings also suggest that the effect of the BDNF Val66Met polymorphism on regional brain volume is dependent on an additional factor, that is, history of CA.
Our results fit nicely with the neurotrophic hypothesis of depression 50 and thus suggest that stress (and depression) can lead to structural brain changes in turn leading to increased stress sensitivity. Therefore, it is crucial that clinicians are aware of this potentially brain-damaging effect of depression and treat depressed patients as early and effectively as possible. 16 Neurotrophic factors have a crucial role in neural plasticity during development and also during adulthood, where they modulate axonal and dendritic growth and remodeling, membrane receptor trafficking, neurotransmitter release as well as synapse formation and function. 51 Indeed, the transcription and secretion of BDNF can be modified by environmental factors such as stress, which can lead to changes in neuronal plasticity and ultimately will affect the function and structure of certain brain areas. Our results could thus be explained by reduced neuronal plasticity in the subgenual ACC.
Neither CA alone nor reduced BDNF secretion alone was sufficient to cause reduced subgenual ACC volume in our samples, the combination of the two factors was critical in causing an effect that we could measure with our approach. It is important to note that this was found in self-reported healthy subjects, suggesting that these structural brain abnormalities indeed may serve as a risk factor for mood disorders and not a consequence of disease or therapy. In line with this, structural brain changes have frequently been identified as endophenotypes for psychiatric disorders, 52 because they can represent an elegant link between genes and psychiatric disorders.
We did not replicate the findings of a preceding study reporting smaller hippocampal and amygdala volumes in carriers of the BDNF Met-allele and a history of two or more childhood events. 17 The differences in findings may be explained best by the methods applied. In the study by Gatt et al., 17 VBM was applied to calculate volumes of pre-defined regions of interest (namely hippocampus, amygdala and medial PFC), whereas we applied a whole-brain approach and looked into pre-specified regions by limiting the search space for statistical testing, in addition. Another difference is the method for assessing CA. Although we used a dichotomized version (one or more CA versus no CA), they looked into total number of CA (ranging from 0 to 5) and found that only in subjects who had experienced two or more CA, there was an interactive effect between BDNF genotype and CA on hippocampal and amygdala volume. Possibly, we found no effect of CA in the hippocampus and amygdala, because within our cohorts, a relatively small group had experienced two or more events before the age of 16 years (15%), which may have resulted in lack of statistical power.
Strengths of our study include the large number of subjects and the ability to replicate our own findings by using two separate cohorts, which decreases the chance of false positive findings. Also, all of our associations were corrected for FWE and thus the results appear to be very robust. Furthermore, we used a whole brain optimized DARTEL VBM approach, which is a fully automatic technique that allows an objective analysis of structural differences between groups across the entire brain. By surveying the whole brain, VBM provides an unbiased measure of highly localized regions that may not be investigated in hypothesis-based studies that employ more laborintensive manual ROI measurement techniques. 53 However, the sensitivity of the DARTEL VBM approach for detecting amygdala and hippocampal volume changes is probably less than the sensitivity of manual tracing of these structures. Possibly, we therefore found no changes in the amygdala and hippocampus in relation to CA and BDNF Val66Met polymorphism, as has previously been reported. 3, 4, 54 History of CA was assessed by means of a questionnaire and it is important to acknowledge the subjectivity of self-reported CA. Retrospective assessment of CA may be subject to recollection bias; persons with higher depressive symptoms might recall more negative events than persons with less depressive symptoms. However, we believe that the influence of negative mood was limited, firstly, because our study was conducted among healthy subjects without psychopathology and secondly, because we adjusted our findings for negative affect and found that current negative mood did not critically affect our results. Also, although the idea that CA in combination with BDNF Val66Met polymorphism is associated with GM volume changes in subgenual ACC fits well with numerous preclinical studies, the possibility of reversed causality (for example, GM volume changes leading to less effective coping with stress, which could lead to over-reporting of CA) cannot be excluded by the current findings as our study had a cross-sectional design.
In summary, the gene-environment interaction affecting local GM volume suggests that BDNF Metallele carriers are particularly sensitive to CA. Given the important role of the subgenual ACC in the regulation of emotional behavior, this finding represents an important link in our understanding of how BDNF in combination with CA contributes to increased stress sensitivity. On the basis of our study, it is however not clear whether Met-allele carriers are more prone to the detrimental effects of stress on the brain, or whether CA leads to decreased GM volume, irrespective of genotype, and normalization is impaired in Met-allele carriers, resulting in GM volume reductions in this group. Future longitudinal studies should therefore aim at unraveling the relation between the susceptibility of BDNF Met-allele carriers to stress on the brain.
